The invention provides characterization of the disease and
cancer-associated antigen, OSM-R.beta. The invention also provides
modulators of OSM-R.beta, including a family of monoclonal antibodies
that bind to antigen OSM-R.beta, and methods of diagnosing and treating
various human cancers and diseases associated with OSM-R.beta.